Secondary Logo

Journal Logo

May 2014 - Volume 109 - Issue 5
pp: 617-782

How Drugs are Developed and Approved by the FDA: Current Process and Future Directions

Ciociola, Arthur A; Cohen, Lawrence B; Kulkarni, Prasad; More

American Journal of Gastroenterology. 109(5):620-623, May 2014.



Abnormal Structure and Function of the Esophagogastric Junction and Proximal Stomach in Gastroesophageal Reflux Disease

Curcic, Jelena; Roy, Shammodip; Schwizer, Alexandra; More

American Journal of Gastroenterology. 109(5):658-667, May 2014.




Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy

Vester-Andersen, Marianne K; Prosberg, Michelle V; Jess, Tine; More

American Journal of Gastroenterology. 109(5):705-714, May 2014.


Irritable Bowel Syndrome in Middle-Aged and Elderly Palestinians: Its Prevalence and Effect of Location of Residence

Qumseya, Bashar J; Tayem, Yasin; Almansa, Cristina; More

American Journal of Gastroenterology. 109(5):723-739, May 2014.


Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders

Galipeau, Heather J; Wiepjes, Michelle; Motta, Jean-Paul; More

American Journal of Gastroenterology. 109(5):748-756, May 2014.


Genome-Wide Association Study Identifies Two Novel Genomic Regions in Irritable Bowel Syndrome

Holliday, Elizabeth G; Attia, John; Hancock, Stephen; More

American Journal of Gastroenterology. 109(5):770-772, May 2014.



Erratum: EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging

Faubion, William A Jr; Fletcher, Joel G; O'Byrne, Sharon; More

American Journal of Gastroenterology. 109(5):780, May 2014.

Show: